FASL-844CC genotype as a predictive factor for poor response to bacillus Calmette-Guerin immunotherapy

• In: SIG Posters
• At: Amsterdam (the Netherlands) (2012)
• Type: Poster
• Poster code: TRI-06
• By: LIMA, Luís (Escola Superior de Tecnologia da Saúde do Politécnico do Porto, Centro de Investigação em Saúde e Ambiente, Vila Nova de Gaia, Portugal)
• Co-author(s): Santos, M. (Escola Superior de Tecnologia da Saúde do Politécnico do Porto, Vila Nova de Gaia, Portugal)
  Morais, A. (Portuguese Institute of Oncology, Porto, Portugal)
  Medeiros, R. (Portuguese Institute of Oncology, Porto, Portugal)
  Santos, L. (Portuguese Institute of Oncology, Porto, Portugal)
  
• Abstract:

  
  Background:
  The most effective option for the treatment of non-muscle invasive bladder cancer during the last 30 years has been the intravesical bacillus Calmette-Guérin (BCG), performed as an adjuvant to transurethral resection of bladder tumour in patients with high grade tumours, T1 tumours and in situ carcinomas. However, 20% to 40% of the

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login